(Q35566836)

8 August 2017

1 reference

title

Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition (English)

1 reference

8 August 2017

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575722

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

24 March 2024

Arup Das

1 reference

8 August 2017

Paul G. McGuire

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575722

24 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14575722

24 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S135094620300065X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

https://api.elsevier.com/content/article/PII:S135094620300065X?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Progress in Retinal and Eye Research

24 March 2024

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

721-748

1 reference

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Perspectives on diabetic retinopathy

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Hypoxic regulation of vascular endothelial growth factor in retinal cells

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A role for local inflammation in the formation of drusen in the aging eye.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Nitric oxide is proangiogenic in the retina and choroid.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Requirement of vascular integrin alpha v beta 3 for angiogenesis

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Characterization of an endogenous metalloproteinase in human vitreous

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Retinal and choroidal neovascularization

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Factors controlling ocular angiogenesis

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Role of the pericyte in wound healing. An ultrastructural study

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Blood vessel maturation: vascular development comes of age

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Granulomatous reaction to Bruch's membrane in age-related macular degeneration

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A new model of experimental choroidal neovascularization in the rat.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Cell turnover of capillaries

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The vascular endothelial growth factor family of polypeptides

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The biology of VEGF and its receptors

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A model of subretinal neovascularization in the pigmented rat.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Basic fibroblast growth factor (bFGF) immunolocalization in the rodent outer retina demonstrated with an anti-rodent bFGF antibody

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Somatostatin analogues as drug therapies for retinopathies.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Systemically expressed soluble Tie2 inhibits intraocular neovascularization

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Altered distribution of basic fibroblast growth factor in diabetic retinopathy

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Endothelial Cells Modulate the Proliferation of Mural Cell Precursors via Platelet-Derived Growth Factor-BB and Heterotypic Cell Contact

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The effect of carbon dioxide on oxygen-induced retinopathy in the neonatal rat

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Metabolic acidosis-induced retinopathy in the neonatal rat

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy

24 March 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

24 March 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Suppression of diabetic retinopathy with angiopoietin-1.

24 March 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vascular permeability factor, an endothelial cell mitogen related to PDGF

24 March 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

24 March 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions

24 March 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

24 March 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Interleukin-8 as a macrophage-derived mediator of angiogenesis

24 March 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Optic nerve injury alters basic fibroblast growth factor localization in the retina and optic tract

24 March 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells

24 March 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

24 March 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

24 March 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials

24 March 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

24 March 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy

24 March 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice

24 March 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

24 March 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells

24 March 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy

24 March 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Effect of a long-acting somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: a pilot study

24 March 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target

24 March 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Visualization of a developing vasculature

24 March 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy

24 March 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy

24 March 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model

24 March 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Insulin-like growth factors. Studies in diabetics with and without retinopathy

24 March 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice

24 March 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin

24 March 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin

24 March 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor

24 March 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The regulation of neovascularization of matrix metalloproteinases and their inhibitors

24 March 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A metalloproteinase inhibitor as an inhibitor of neovascularization

24 March 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin

24 March 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Enhancement of FGF-like polypeptides in the retinae of newborn mice exposed to hyperoxia

24 March 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells

24 March 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells

24 March 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes

24 March 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment

24 March 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

24 March 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

24 March 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells

24 March 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis

24 March 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates

24 March 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization

24 March 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

24 March 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy

24 March 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Variable oxygen exposure causes preretinal neovascularization in the newborn rat

24 March 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Oxygen-induced retinopathy in the rat

24 March 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity

24 March 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

24 March 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Proteolytic balance and capillary morphogenesis

24 March 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

24 March 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

24 March 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Recovery from retinopathy in a case of diabetes with Simmonds' disease

24 March 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Regulation of angiogenesis by hypoxia: role of the HIF system

24 March 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

24 March 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

24 March 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

24 March 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

24 March 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization

24 March 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

24 March 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Immunolocalization of integrins in proliferative retinal membranes

24 March 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy

24 March 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

TIMP-3 is expressed in the human retinal pigment epithelium

24 March 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Subretinal neovascularization. Natural history of an experimental model

24 March 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization.

24 March 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system

24 March 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

HIF-1: using two hands to flip the angiogenic switch

24 March 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor

24 March 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Basic Fibroblast Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy

24 March 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Oxygen-induced retinopathy in the mouse

24 March 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Essential role of growth hormone in ischemia-induced retinal neovascularization

24 March 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Basement membrane and growth factor gene expression in normal and diabetic human retinas

24 March 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

24 March 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family

24 March 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

24 March 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.

24 March 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

24 March 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Expression of thrombospondin-1 in ischemia-induced retinal neovascularization

24 March 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization

24 March 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

24 March 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Angiopoietin-1 protects the adult vasculature against plasma leakage.

24 March 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model

24 March 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

24 March 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1.

24 March 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

24 March 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Photoreceptor-specific overexpression of platelet-derived growth factor induces proliferation of endothelial cells, pericytes, and glial cells and aberrant vascular development: an ultrastructural and immunocytochemical study

24 March 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy

24 March 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina

24 March 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vascular-specific growth factors and blood vessel formation

24 March 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

Vascular endothelial growth factor expression in choroidal neovascularization in rats

24 March 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.PRETEYERES.2003.08.001

24 March 2024

Identifiers

1 reference

8 August 2017

1 reference